Intranasal Vaccination against HIV-1 with Adenoviral Vector-Based Nanocomplex Using Synthetic TLR-4 Agonist Peptide as Adjuvant.

Li, Man

Intranasal Vaccination against HIV-1 with Adenoviral Vector-Based Nanocomplex Using Synthetic TLR-4 Agonist Peptide as Adjuvant. [electronic resource] - Molecular pharmaceutics Mar 2016 - 885-94 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1543-8392

10.1021/acs.molpharmaceut.5b00802 doi


AIDS Vaccines--administration & dosage
Adenoviridae--genetics
Adjuvants, Immunologic
Administration, Intranasal
Animals
Cell Proliferation
Cells, Cultured
Dendritic Cells--immunology
Dogs
Drug Carriers
Female
Genetic Vectors--administration & dosage
HIV Infections--immunology
HIV-1--immunology
Humans
Immunity, Mucosal
Madin Darby Canine Kidney Cells
Mice
Mice, Inbred BALB C
Nanostructures--chemistry
Nasal Mucosa--immunology
Peptide Fragments--immunology
T-Lymphocytes, Cytotoxic--immunology
Toll-Like Receptor 4--agonists
Vaccination